Clinical Trial Update: Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of propylene glycol-free melphalan HCl for myeloablative conditioning in autologous stem cell transplant for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• melphalan HCl (propylene glycol-free formulation) (melphalan)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2018-10-10